{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:28:55Z","timestamp":1790630935412,"version":"4.1.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00259-025-07179-1","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T02:48:17Z","timestamp":1741661297000},"page":"3145-3150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Achieving Complete Pathologic Necrosis in Hepatocellular Carcinoma Treated with Radiation Segmentectomy before Liver Transplantation: A Comprehensive Glass Microsphere Analysis"],"prefix":"10.1007","volume":"52","author":[{"given":"S. Ali","family":"Montazeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"De la Garza-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Paz-Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau B.","family":"Toskich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"7179_CR1","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1007\/s00259-022-05776-y","volume":"49","author":"SA Montazeri","year":"2022","unstructured":"Montazeri SA, De la Garza-Ramos C, Lewis AR, Lewis JT, LeGout JD, Sella DM, et al. Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors. Eur J Nucl Med Mol Imaging. 2022;49:3892\u20137. https:\/\/doi.org\/10.1007\/s00259-022-05776-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7179_CR2","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00261-017-1354-6","volume":"43","author":"AF Ahmed","year":"2018","unstructured":"Ahmed AF, Samreen N, Grajo JR, Zendejas I, Sistrom CL, Collinsworth A, et al. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma. Abdom Radiol. 2018;43:1825\u201336.","journal-title":"Abdom Radiol"},{"key":"7179_CR3","doi-asserted-by":"crossref","unstructured":"Sandow T, Gimenez J, Nunez K, Tramel R, Gilbert P, Oliver B et al. Using Voxel-Based Dosimetry to Evaluate Sphere Concentration and Tumor Dose in Hepatocellular Carcinoma Treated with Yttrium-90 Radiation Segmentectomy with Glass Microspheres. Journal of Vascular and Interventional Radiology. 2024;35:1602-12. e1.","DOI":"10.1016\/j.jvir.2024.05.020"},{"key":"7179_CR4","doi-asserted-by":"crossref","unstructured":"Pianka KT, Barahman M, Minocha J, Redmond JW, Schnickel GT, Rose SC et al. Voxel-based tumor dose correlates to complete pathologic necrosis after transarterial radioembolization for hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2024:1\u20139.","DOI":"10.1007\/s00259-024-06813-8"},{"key":"7179_CR5","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1007\/s00259-022-05819-4","volume":"49","author":"C Chiesa","year":"2022","unstructured":"Chiesa C, Mazzaglia S, Maccauro M. Spatial density and tumor dosimetry are important in radiation segmentectomy with 90Y glass microspheres. Eur J Nucl Med Mol Imaging. 2022;49:3607\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7179_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00259-019-04588-x","volume":"47","author":"AS Pasciak","year":"2020","unstructured":"Pasciak AS, Abiola G, Liddell RP, Crookston N, Besharati S, Donahue D, et al. The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure. Eur J Nucl Med Mol Imaging. 2020;47:816\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7179_CR7","doi-asserted-by":"publisher","unstructured":"Taswell CS, Studenski M, Pennix T, Stover B, Georgiou M, Venkat S, et al. For hepatocellular carcinoma treated with Yttrium-90 microspheres, dose volumetrics on Post-Treatment Bremsstrahlung SPECT\/CT predict clinical outcomes. Cancers (Basel). 2023;15. https:\/\/doi.org\/10.3390\/cancers15030645.","DOI":"10.3390\/cancers15030645"},{"key":"7179_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","volume":"7","author":"E Kim","year":"2022","unstructured":"Kim E, Sher A, Abboud G, Schwartz M, Facciuto M, Tabrizian P, et al. Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study. Lancet Gastroenterol Hepatol. 2022;7:843\u201350. https:\/\/doi.org\/10.1016\/S2468-1253(22)00091-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7179_CR9","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/hep.31819","volume":"74","author":"R Salem","year":"2021","unstructured":"Salem R, Johnson GE, Kim E, Riaz A, Bishay V, Boucher E, et al. Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study. Hepatology. 2021;74:2342\u201352. https:\/\/doi.org\/10.1002\/hep.31819.","journal-title":"Hepatology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07179-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07179-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:52:29Z","timestamp":1751435549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07179-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7179"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07179-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Mayo Clinic Institutional Review Board (IRB). This study was compliant with the Health Insurance Portability and Accountability Act.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable per retrospective design. The need for informed consent was waived by Mayo Clinic IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"B.B.T. is an advisor to Boston Scientific, Sirtex Medical, Terumo Medical, ABK, Galvanize Therapeutics, Replimmune, Johnson and Johnson, AstraZeneca, Genentech, VIVOS, HistoSonics, Eisai, Replimmune, and Delcath.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}